NASDAQ:BRKR - Bruker Stock Price, News, & Analysis

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Bruker announced a quarterly dividend on Monday, August 13th. Stockholders of record on Tuesday, September 4th will be given a dividend of $0.04 per share on Friday, September 21st. This represents a $0.16 annualized dividend and a dividend yield of 0.49%. The ex-dividend date is Friday, August 31st. View Bruker's Dividend History.

Bruker announced that its Board of Directors has initiated a stock buyback program on Sunday, June 4th 2017, which allows the company to repurchase $225,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's board of directors believes its shares are undervalued.

Bruker Co. (NASDAQ:BRKR) announced its earnings results on Thursday, August, 2nd. The medical research company reported $0.25 EPS for the quarter, hitting the Zacks' consensus estimate of $0.25. The medical research company earned $443.70 million during the quarter, compared to the consensus estimate of $436.10 million. Bruker had a net margin of 4.99% and a return on equity of 27.03%. Bruker's quarterly revenue was up 6.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.23 earnings per share. View Bruker's Earnings History.

Bruker is scheduled to release their next quarterly earnings announcement on Thursday, November, 1st 2018. View Earnings Estimates for Bruker.

Bruker issued an update on its FY18 earnings guidance on Thursday, August, 2nd. The company provided earnings per share (EPS) guidance of $1.34-1.38 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.38. The company issued revenue guidance of approx $1.88 billion, compared to the consensus revenue estimate of $1.88 billion.

9 equities research analysts have issued 1-year target prices for Bruker's stock. Their forecasts range from $24.00 to $42.00. On average, they expect Bruker's share price to reach $33.2222 in the next twelve months. This suggests a possible upside of 1.1% from the stock's current price. View Analyst Price Targets for Bruker.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 2 sell ratings, 6 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Bruker.

Some companies that are related to Bruker include Mettler-Toledo International (MTD), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Harvard Bioscience (HBIO), Eyepoint Pharmaceuticals (EYPT), HTG Molecular Diagnostics (HTGM) and Arrayit (ARYC).

Bruker's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include FMR LLC (4.75%), BlackRock Inc. (3.43%), Acadian Asset Management LLC (3.02%), Millennium Management LLC (0.82%), Epoch Investment Partners Inc. (0.72%) and Dimensional Fund Advisors LP (0.62%). Company insiders that own Bruker stock include Frank H Laukien, Ingen Chris Van, Mark Munch and Richard Kniss. View Institutional Ownership Trends for Bruker.

BRKR stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Acadian Asset Management LLC, First Trust Advisors LP, Sensato Investors LLC, Janus Henderson Group PLC, First Quadrant L P CA, Eagle Asset Management Inc. and Renaissance Technologies LLC. View Insider Buying and Selling for Bruker.

BRKR stock was purchased by a variety of institutional investors in the last quarter, including Epoch Investment Partners Inc., Citadel Advisors LLC, Fuller & Thaler Asset Management Inc., Los Angeles Capital Management & Equity Research Inc., Point72 Asset Management L.P., Millennium Management LLC, CWM LLC and MUFG Securities EMEA plc. View Insider Buying and Selling for Bruker.

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BRKR stock can currently be purchased for approximately $32.87.

Bruker has a market capitalization of $5.11 billion and generates $1.77 billion in revenue each year. The medical research company earns $78.60 million in net income (profit) each year or $1.21 on an earnings per share basis. Bruker employs 6,200 workers across the globe.

The official website for Bruker is http://www.bruker.com.

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at 978-663-3660 or via email at [email protected]